デフォルト表紙
市場調査レポート
商品コード
1363960

カンナビジオールオイルの世界市場:2023-2030年

Global Cannabidiol Oil Market 2023-2030

出版日: | 発行: Orion Market Research | ページ情報: 英文 95 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
カンナビジオールオイルの世界市場:2023-2030年
出版日: 2023年09月22日
発行: Orion Market Research
ページ情報: 英文 95 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のカンナビジオールオイル市場は、予測期間中に16.3%のかなりのCAGRで成長すると予想されています。カンナビジオールの利点とその薬効についての意識の高まりは、その需要を牽引しており、それが更に世界のカンナビジオールオイル市場の成長につながっています。さらに、体の痛みを軽減するヘンプオイルの製薬業界における高い採用率は、市場の成長にさらに貢献しています。政府の承認によってCBD製品の受け入れと使用が増加していることは、生産と販売を後押しし、それによって市場の成長に貢献すると予想されます。CBDは不安、発作、痛みなどの症状を効果的に治療します。

さらに、治療分野におけるCBDオイルの有用性を見出すための研究開発活動が進行中であることが、市場成長の可能性をさらに生み出しています。例えば、2021年6月に発表されたミシガン大学の研究によると、線維筋痛症患者878人のうち、72.0%の患者が疼痛管理にCBDを使用し、CBDは他の薬物療法と比較して疼痛の軽減に役立ったと報告しています。このように、消費者の意見の変化とともに、CBDオイルベースの製品が広く使用されていることが、市場成長の原動力となっています。しかし、厳しい規制政策や副作用、偽造品の存在が世界のカンナビジオールオイル市場の成長を抑制しています。

セグメント別展望

麻ベースが主要市場シェアを占める

ヘンプベースのCBDオイルは、2022年の世界市場で主要シェアを占めました。このセグメントは、予測期間中に最も速いCAGRを示すと予測されています。製薬業界からの製品需要の高まりと、その健康効果に関する消費者の意識の高まりが、この市場セグメントの高いシェアの主な要因となっています。さらに、薬用大麻の合法化と消費者の可処分所得水準の向上が、製薬分野における麻ベースのCBDの需要を促進すると予測されています。

地域別展望

世界のカンナビジオールオイル市場は、北米(米国とカナダ)、欧州(イタリア、スペイン、ドイツ、フランス、その他)、アジア太平洋(インド、中国、日本、韓国、その他)、世界のその他の地域(中東とアフリカ、ラテンアメリカ)を含む地域に基づいてさらにセグメント化されます。アジア太平洋は予測期間中、カンナビジオールオイル市場で最も速いCAGRを示すと予想されています。

北米がカンナビジオールオイルの世界市場で大きなシェアを占める

北米は世界のカンナビジオールオイル市場で大きなシェアを占めています。この地域の美容・化粧品産業の成長、いくつかの医薬品におけるCBDオイルの高い採用率、主要な市場プレイヤーの存在は、この地域の市場の成長を促進する主な要因です。さらに、治療分野におけるCBDオイルの有用性を見出すための研究開発活動が進行中であることも、この地域の市場成長の可能性をさらに生み出しています。

例えば、2021年3月、Advanced Pain and Rehab Specialists社は、Hemp synergistic社と共同で、痛み、不安、不眠症の治療、オピオイド使用の削減に対するヘンプオイル(CBD)の有効性を評価する第I相臨床試験を実施しました。さらに2021年6月、ヴァレンス社はグリーンロード社とその製造子会社の買収を完了しました。この買収により、Valens Companyはカンナビノイドオイル市場で最大手の一角を占めることになると予想されます。同地域における市場プレイヤーの活動が活発化することで、同地域における製品の入手可能性が高まると予想されます。

2022年12月、Medterra社は、顧客の日常的なニーズに応える革新的なインスタント・デリバリー・プラットフォームであるGopuff社との全国的な販売提携を発表しました。メデラはこの夏、アリゾナ州、カリフォルニア州、ペンシルベニア州、イリノイ州の住民を対象に、一部の市場でGopuffの販売を正式に開始し、現在はさらに26の市場に進出しており、2022年と2023年にかけてさらなる拡大を計画しています。このような拡大計画は、新たな市場での市場成長の新たな可能性を生み出しています。

目次

第1章 レポート概要

  • 業界の現状分析と成長可能性の展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Medical Marijuana, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • ConnOils LLC
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • NuLeaf Naturals, LLC
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Elixinol
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向

第4章 市場の決定要因

  • 促進要因
  • 抑制要因
  • 機会

第5章 市場セグメンテーション

  • 世界のカンナビジオールオイル市場:製品別
    • マリファナベース
    • ヘンプベース
  • 世界のカンナビジオールオイル市場:用途別
    • 多発性硬化症
    • うつ病・睡眠障害
    • 神経性疼痛
    • その他の用途

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 世界のその他の地域

第7章 企業プロファイル

  • Aurora Cannabis
  • Canopy Growth Corp.
  • CBD American Shaman
  • ConnOils LLC
  • CV Sciences Inc.
  • Elixinol
  • ENDOCA
  • Folium Europe B.V.
  • Gaia Herbs
  • Hempstrol
  • High Tide, Inc.
  • IRIE CBD
  • Isodiol International Inc
  • Medical Marijuana, Inc.
  • NuLeaf Naturals, LLC
図表

LIST OF TABLES

  • 1. GLOBAL CANNABIDIOL OIL MARKET BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL MARIJUANA BASED CANNABIDIOL OIL MARKET BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL HEMP BASED CANNABIDIOL OIL MARKET BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL CANNABIDIOL OIL MARKET BY APPLICATION, 2022-2030 ($ MILLION)
  • 5. GLOBAL CANNABIDIOL OIL FOR MULTIPLE SCLEROSIS TREATMENT MARKET BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL CANNABIDIOL OIL FOR DEPRESSION AND SLEEP DISORDERS TREATMENT MARKET BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL CANNABIDIOL OIL FOR NEUROLOGICAL PAIN TREATMENT MARKET BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL CANNABIDIOL OIL FOR OTHER APPLICATION MARKET BY REGION,2022-2030 ($ MILLION)
  • 9. GLOBAL CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13. EUROPEAN CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 14. EUROPEAN CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 15. EUROPEAN CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. ASIA-PACIFIC CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 17. ASIA-PACIFIC CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 18. ASIA-PACIFIC CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CANNABIDIOL OIL MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL CANNABIDIOL OIL MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 3. GLOBAL CANNABIDIOL OIL MARKET SHARE BY GEOGRAPHY, 2022 VS 2030, (%)
  • 4. GLOBAL MARIJUANA BASED CANNABIDIOL OIL MARKET BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL HEMP BASED CANNABIDIOL OIL MARKET BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL CANNABIDIOL OIL FOR MULTIPLE SCLEROSIS TREATMENT MARKET BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL CANNABIDIOL OIL FOR DEPRESSION AND SLEEP DISORDERS TREATMENT MARKET BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL CANNABIDIOL OIL FOR NEUROLOGICAL PAIN TREATMENT MARKET BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL CANNABIDIOL OIL FOR OTHER APPLICATION MARKET BY REGION, 2022 VS 2030 (%)
  • 10. US CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. CANADA MARKET CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. UK CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. GERMANY CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. SPAIN CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. FRANCE CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. ITALY CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. REST OF EUROPE CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. INDIA CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. CHINA CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. JAPAN CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF ASIA-PACIFIC CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF WORLD CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027715

Title: Global Cannabidiol oil Market Size, Share & Trends Analysis Report Market, By Product Type (Marijuana Based, Hemp Based), By Application (Multiple Sclerosis, Depression and Sleep Disorders, Neurological Pain, Other Application)Forecast Period (2023-2030).

The global cannabidiol oil market is anticipated to grow at a considerable CAGR of 16.3% during the forecast period. The increased awareness about the benefits of cannabidiol and its medicinal properties has driven its demand; which in turn driving the growth of the global cannabidiol oil. Additional, the high adoption of hemp oil in pharmaceutical industries as it reduces the body pain is a positive sign is further contributing to the market growth. The increasing acceptance and use of CBD products due to government approvals is anticipated to boost production and sales, thereby contributing to the market growth. CBD effectively treats conditions, such as anxiety, seizures, and pain.

Moreover, the ongoing R&D activities in finding the utility of CBD oil in therapeutic areas is further creating scope for the market growth. For instance, according to a study from Michigan University published in June 2021, out of 878 patients with fibromyalgia, 72.0% of patients reported using CBD to manage their pain, and CBD helped decrease their pain compared to other drug therapies. Thus, the widespread use of CBD oil-based products, along with changing consumer opinion has been driving the market growth. However, stringent regulatory policies and side effects, and availability counterfeit products are restraining the growth of the global cannabidiol oil market.

Segmental Outlook

The global cannabidiol oil market is segmented based on product type and application. Based on product type, the market is segmented into marijuana based, and hemp based. Based on application, the market is segmented into multiple sclerosis, depression and sleep disorders, neurological pain, and other application.

Hemp Based to Hold Major Market Share

The hemp based CBD oil held major share in the global market in 2022. This segment is projected to exhibit the fastest CAGR during the forecast period. The rising product demand from the pharmaceutical industry and growing consumer awareness about its health benefits is a key contributor to the high share of this market segment. Moreover, legalizing medicinal cannabis and increasing consumer disposable income levels are projected to fuel the demand for hemp based CBD in the pharmaceutical sector.

Regional Outlook

The global cannabidiol oil market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit fastest CAGR in the cannabidiol oil market during the forecast period.

North America Held Significant Share in the Global Cannabidiol Oil Market

North America held significant share in the global cannabidiol oil market. The growing beauty & cosmetic industry of the region, high adoption of CBD oil in several medicines, along with the presence of key market players are key factors driving the growth of the regional market. Moreover, the ongoing R&D activities in finding the utility of CBD oil in therapeutic areas is further creating scope for the regional market growth.

For instance, in March 2021, Advanced Pain and Rehab Specialists, in collaboration with Hemp synergistic, conducted a phase I clinical trial to assess the efficacy of Hemp Oil (CBD) for treating pain, anxiety, insomnia, and reduction of opioid use. Additionally, in June 2021, The Valens Company Inc. completed the acquisition of Green Roads and its manufacturing subsidiary. With this acquisition, Valens Company is anticipated to have one of the largest players in the cannabinoid oil market. The increasing market player's activities in the region are expected to increase product availability in the region.

Market Players Outlook

The major companies serving the global cannabidiol oil market include Aurora Cannabis, Medical Marijuana, Inc., ConnOils LLC, NuLeaf Naturals, LLC, and Elixinol among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, dealership expansion, and new product launches, to stay competitive in the market. For instance, in February 2023, Multi-platinum entertainer Sara Evans has partnered with Nashville-based CeleBriDy Brands to develop Born to Fly CBD by Sara Evans. The luxurious new product line is available in both an oil tincture and as a topical roll-on for fast, targeted pain relief.

In December 2022, Medterra has announced a national distribution partnership with Gopuff, the innovative, instant delivery platform for customers' daily needs. Medterra officially launched on Gopuff this past Summer in select markets, for residents in Arizona, California, Pennsylvania and Illinois and is now in 26 additional markets with further plans for expansion through 2022 and 2023. Such expansion plans are creating new scope for the market growth in new markets.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global cannabidiol oil market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Medical Marijuana, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. ConnOils LLC
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. NuLeaf Naturals, LLC
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Elixinol
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Cannabidiol Oil Market by Product
    • 5.1.1. Marijuana Based
    • 5.1.2. Hemp Based
  • 5.2. Global Cannabidiol Oil Market by Application
    • 5.2.1. Multiple Sclerosis
    • 5.2.2. Depression and Sleep Disorders
    • 5.2.3. Neurological Pain
    • 5.2.4. Other Application

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Aurora Cannabis
  • 7.2. Canopy Growth Corp.
  • 7.3. CBD American Shaman
  • 7.4. ConnOils LLC
  • 7.5. CV Sciences Inc.
  • 7.6. Elixinol
  • 7.7. ENDOCA
  • 7.8. Folium Europe B.V.
  • 7.9. Gaia Herbs
  • 7.10. Hempstrol
  • 7.11. High Tide, Inc.
  • 7.12. IRIE CBD
  • 7.13. Isodiol International Inc
  • 7.14. Medical Marijuana, Inc.
  • 7.15. NuLeaf Naturals, LLC